Senate: Medtronic shaped articles Promoting InFuse

| No Comments
Pin It

A Senate report out Thursday concludes Medtronic helped write and edit medical journal articles attributed to outside physicians which downplayed the risks of InFuse, the company's best-selling bone graft, responsible for $800 million in annual sales.

Steven Miles, M.D., Bioethics, University of Minnesota Medical School, says such practices are endemic in an industry with very little oversight

More on: WCCO Radio

Leave a comment